| 000 | 01786 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517114841.0 | ||
| 264 | 0 | _c20170329 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1525-3198 | ||
| 024 | 7 |
_a10.3168/jds.2016-11134 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGonggrijp, M A | |
| 245 | 0 | 0 |
_aPrevalence and risk factors for extended-spectrum β-lactamase- and AmpC-producing Escherichia coli in dairy farms. _h[electronic resource] |
| 260 |
_bJournal of dairy science _cNov 2016 |
||
| 300 |
_a9001-9013 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aBacterial Typing Techniques |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 |
_aCattle Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aCephalosporins _xpharmacology |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aDairying |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xmicrobiology |
| 650 | 0 | 4 |
_aFeces _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aPlasmids _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 |
_abeta-Lactamases _xbiosynthesis |
| 700 | 1 | _aSantman-Berends, I M G A | |
| 700 | 1 | _aHeuvelink, A E | |
| 700 | 1 | _aButer, G J | |
| 700 | 1 | _avan Schaik, G | |
| 700 | 1 | _aHage, J J | |
| 700 | 1 | _aLam, T J G M | |
| 773 | 0 |
_tJournal of dairy science _gvol. 99 _gno. 11 _gp. 9001-9013 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3168/jds.2016-11134 _zAvailable from publisher's website |
| 999 |
_c26427300 _d26427300 |
||